14,15-Epoxyeicosatrienoic acid | 81276-03-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 14,15-Epoxyeicosatrienoic acid
• 英文别名: (5E,8E,11E)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid
• CAS: 81276-03-1；105304-92-5
• 化学式: C₂₀H₃₂O₃
• 分子量: 320.5
• InChiKey: JBSCUHKPLGKXKH-JFGLUDJCSA-N

物化性质

• 溶解度：
  可溶于乙醇

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  23
• 可旋转键数：
  14
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  F,Xi
• 危险类别码：
  R36/37/38,R11
• 危险品运输编号：
  UN 1170 3/PG 2
• 安全说明：
  S16,S26,S36

文献信息

• SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF
  申请人：The United States of America, as represented by the Secretary, Department of Health and Human Serv

  公开号：US20130302247A1

  公开（公告）日：2013-11-14

  There are provided, inter alia, methods for diagnosis of the extent of neuroinflammation in a subject. The methods include administering an 18 F-labeled arachidonic acid to a subject in need thereof, obtaining a positron emission tomography (PET) scan of the subject, and determine the extent of neuroinflammation from the PET scan. There are provided, inter alia, methods of synthesis of reagents useful for the production of an 18 F-labeled arachidonic acid.

  提供了诊断受试者神经炎症程度的方法，其中包括向需要的受试者施用18F标记的花生四烯酸，获取受试者的正电子发射断层扫描（PET扫描），并根据PET扫描确定神经炎症的程度。此外，还提供了合成试剂的方法，用于生产18F标记的花生四烯酸。
• Compounds and methods for inhibiting Cif virulence factor
  申请人：Trustees of Dartmouth College

  公开号：US10322118B2

  公开（公告）日：2019-06-18

  The present invention provides a screening assay for identifying inhibitors of Pseudomonas aeruginosa CFTR Inhibitory Factor as well as compositions and methods for ameliorating or treating a respiratory disease such as cystic fibrosis or secondary infection thereof.

  本发明提供了一种用于鉴定铜绿假单胞菌 CFTR 抑制因子抑制剂的筛选试验，以及用于改善或治疗呼吸道疾病（如囊性纤维化）或继发感染的组合物和方法。
• COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR
  申请人：Trustees of Dartmouth College

  公开号：US20150045389A1

  公开（公告）日：2015-02-12

  The present invention is a screening assay for identifying inhibitors of Pseudomonas aeruginosa CFTR Inhibitory Factor as well as compounds identified by the screening assay for use in compositions and methods for ameliorating or treating a respiratory disease such as cystic fibrosis or secondary infection thereof.
• METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT
  申请人：CHILDREN'S MEDICAL CENTER CORPORATION

  公开号：US20150246075A1

  公开（公告）日：2015-09-03

  Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.
• DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM
  申请人：THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

  公开号：US20160209428A1

  公开（公告）日：2016-07-21

  The disclosure provides for methods that integrate metabolic testing results from a patient's biological sample for predicting or diagnosing neurological disease and disorders.